7801 - 7810 of 9030 Results
Title
Year
-
OPENTitle: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 30Issue #: 11Start Page: 3853End Page: 3859Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201600756rBest OA location URL: http://doi.org/10.1096/fj.201600756RCitation Count: 407
-
OPENTitle: A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function TestsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00011Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00011/pdfCitation Count: 43
-
OPENTitle: Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethalityJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41467-026-71351-wBest OA location URL: https://doi.org/10.1038/s41467-026-71351-wCitation Count: 1
-
OPENTitle: Gait Parameters Measured from Wearable Sensors Reliably Detect Freezing of Gait in a Stepping in Place TaskJournal Name: SensorsPublisher: MDPI AGVol: 21Issue #: 8Start Page: 2661End Page: 2661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s21082661Best OA location URL: https://www.mdpi.com/1424-8220/21/8/2661/pdf?version=1618032463Citation Count: 13
-
OPENTitle: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 748End Page: 759Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/113416685/MainText_Politis_RevisedManuscript_Clean.pdfCitation Count: 96
- Shifting the trajectory of therapeutic development for neurological and psychiatric disorders2023RESTRICTEDTitle: Shifting the trajectory of therapeutic development for neurological and psychiatric disordersJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 15Issue #: 720Start Page: eadg4775End Page: eadg4775Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adg4775Citation Count: 12
-
OPENTitle: Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 3Start Page: 1483End Page: 1491Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-12073-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-12073-7.pdfCitation Count: 13
-
OPENTitle: R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 475End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02325-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02325-z.pdfCitation Count: 84
-
OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 19704End Page: 19704Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 3
- A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 140